Strong analyst confidence in Intelligent Surgery ( ISRG ) amid company’s continued push to expand footprint


Intuitive Surgical Inc. (NASDAQ:ISRG) is one of them 10 Best Large Cap Growth Stocks to Buy.

Strong analyst confidence in Intelligent Surgery ( ISRG ) amid company's continued push to expand footprint
Strong analyst confidence in Intelligent Surgery ( ISRG ) amid company’s continued push to expand footprint

Many analysts are still bullish on Intuitive Surgical, Inc. (NASDAQ:ISRG) has a positive outlook. A consensus price target of around $620 suggests an upside of 26.49%, with around 68% of analysts covering the stock remaining bullish. Shares have risen nearly 5% over the past six months, matching the 5% gain in the medical devices and supplies sector. Despite this, in the last year the psychological surgery has decreased by about 9%, while the industry has decreased by about 2%. Intuitive Surgical Inc. (NASDAQ:ISRG) continues to build on its clinical capabilities and geographic reach, maintaining analyst confidence. To strengthen its direct presence in Italy, Spain, Portugal, Malta, and San Marino, Intuitive Surgical Inc. (NASDAQ:ISRG) said on March 2, 2026 that it completed the acquisition of Da Vinci and Avon distribution businesses operated by ab medica, Abex, and Excelencia Robó. This change not only encourages the implementation of minimally invasive technology in Southern Europe but also allows for stronger coordination with healthcare providers. As of December 31, 2025, 470 da Vinci surgical systems remain installed in the region. In addition, the US Food and Drug Administration (FDA) has approved the Daunci 5 system for certain cardiac procedures, such as mitral valve replacement. The move will strengthen Intuitive Surgical, Inc.’s (NASDAQ:ISRG) technology base and expand the scope of surgeries that can be performed with robot-assisted technology. Intuitive Surgical Inc. (NASDAQ:ISRG) is a company that provides a wide range of goods and services. Through this, the company offers minimally invasive treatment and robotic-assisted surgery solutions. While we recognize ISRG’s potential as an investment, we believe some AI stocks offer more potential and lower risk. If you’re looking for the most undervalued AI stocks that stand to benefit significantly from Trump-era tariffs and the offshore trend, check out our free report Best short-term AI stocks. Read more: 33 stocks that should double in 3 years and 15 Stocks That Will Make You Rich in 10 Years Disclosure: None. Follow the inside port on Google News.

Add Comment